Form 4: Surmodics SVP Charles Olson Reports Stock Option Exercise and Tax Withholding
SEC Form 4 Filing
Charles Olson, SVP at Surmodics, exercised stock options and sold shares to cover tax obligations on August 16, 2024.
Summary
- On August 16, 2024, Charles W. Olson, SVP of Medical Device Coatings at Surmodics Inc., exercised employee stock options, acquiring 18,447 shares of common stock at a price of $33.20.
- Following the exercise, Olson disposed of 16,727 shares of common stock at a price of $40.06 to cover tax obligations related to the option exercise.
- After these transactions, Olson directly owns 53,971 shares of Surmodics common stock and indirectly owns 800 shares through an IRA.
- The exercised options were fully vested and exercisable as of August 16, 2024, with an original grant date of November 28, 2024.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects routine transactions related to stock options and tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for maintaining market confidence and regulatory compliance.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 11/28/2024 | Original grant date of the employee stock options |
| 08/16/2024 | Date of stock option exercise and share disposal |
| 08/20/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.